• Methaqualone, Urine
  • Hydroxyzine, Serum
  • Alpha 1 Microglobulin, 24 Hour, Urine
  • Aspergillus DNA, Qualitative, Real-Time PCR, CSF
  • PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio
  • Liver Cytosolic Antigen Type 1 (LC-1) Antibody, IgG
  • Culture, Prostatic Secretion
  • Severe Combined Immunodeficiency Gene Panel, NGS
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Clinical Utility
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.